Huhtamaki has acquired full ownership of its paper bag joint venture in Poland

Flint Group Packaging Inks, one of the largest ink and coatings suppliers to the global print and packaging industry, has enhanced its solvent-based range of inks and coatings for European customers. The new ONECode range is designed simplify the flexible packaging printing process, reducing process waste and increasing ease in doing business. "Under the ONECode brand, we have built a new product hierarchy including six new brands," says Kim Melander, Vice President & General Manager for Packaging Inks Europe, "These ink systems, developed to unlock the complex landscape of flexible package printing, to connect, clarify, and bring transparency to the flexible packaging printing industry.” Mr. Melander continues, “Flint Group Packaging Inks’ ONECode range will guarantee printers and converters innovative, reliable, and sustainable ink solutions that deliver the highest performance possible from your most simple to your most demanding applications.”

Call to correct mistakes in proposed amendments to EU Packaging and Packaging Waste Regulation that will penalize recyclable materials, like cardboard, while promoting the plastics industry. Imagine you’re in charge of regulating packaging in the European Union. You’re bringing in some new rules to reduce waste and pollution. So far, so good. But then it is revealed that an amendment mandating the reuse of packaging will cause a flood of plastic. That is exactly the opposite of what you’re trying to achieve. Do you vote for it anyway? The answer is obvious. Yet this is the exact dilemma now facing the EU, as it debates proposed amendments to the Packaging and Packaging Waste Regulation (PPWR).

Pharmaceutical product packaging accounts for a large part of manufacturers’ Scope 3 emissions, which consider, for example raw material production, manufacturing, and end-of-life disposal. According to Metsä Board studies, fresh fibre paperboard can notably reduce the carbon footprint of pharmaceutical packaging by optimising the paperboard in use. Assessments* conducted by Metsä Board demonstrate the significant carbon footprint reductions that pharmaceutical manufacturers can achieve by switching from commonly used grades to Metsä Board fresh fibre paperboards. The lower carbon footprint of Metsä Board’s folding boxboards, compared to the above mentioned boards, is due to the use of fossil free energy in their production and their lighter weight. However, despite the lighter weight, Metsä Board’s folding boxboards still retain the durability and functional properties of traditional heavier grades.